Hugh Griffith
Founder chez NUCANA PLC
Fortune : 328 907 $ au 31/03/2024
Profil
Hugh Stephen Griffith is the founder of NuCana Plc, a company founded in 1997, where he currently holds the title of Chief Executive Officer & Executive Director.
He was also the founder of Alida Capital International Ltd., founded in 2009, where he held the title of Chief Executive Officer & Director.
Additionally, he is the founder of EdixoMed Ltd., founded in 2009, where he holds the title of Non-Executive Director, and MedAnnex Ltd., also founded in 2009, where he holds the title of Non-Executive Director.
In addition to his founding positions, Mr. Griffith has held former job positions.
He was the Executive Commercial Director at Ernco 200 LTD in 2002.
He served as a Non-Executive Director at Thirty Holdings Ltd.
He worked as the Manager-Business Development at Abbott Laboratories from 1995 to 2001.
From 2002 to 2007, he was the Chief Operating Officer at Bioenvision, Inc. He also held the position of Principal at Parke-Davis & Co. Ltd.
and Warner Lambert (UK) Ltd.
from 1992 to 1995.
Mr. Griffith's education includes an undergraduate degree from The University of Stirling and an MBA from Cardiff Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUCANA PLC
3,98% | 31/12/2023 | 1 265 026 ( 3,98% ) | 328 907 $ | 31/03/2024 |
Postes actifs de Hugh Griffith
| Sociétés | Poste | Début |
|---|---|---|
| NUCANA PLC | Founder | 28/01/1997 |
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The private company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Founder | 01/01/2009 |
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Founder | 01/01/2009 |
Anciens postes connus de Hugh Griffith
| Sociétés | Poste | Fin |
|---|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Chief Operating Officer | 01/01/2007 |
Ernco 200 LTD
 Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Corporate Officer/Principal | 01/09/2002 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/12/2001 |
Warner Lambert (UK) Ltd.
 Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The private company is based in Eastleigh, UK. | Corporate Officer/Principal | 01/10/1995 |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Director/Board Member | - |
Formation de Hugh Griffith
| The University of Stirling | Undergraduate Degree |
| Cardiff Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| NUCANA PLC | Health Technology |
| Entreprise privées | 8 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Health Technology |
Ernco 200 LTD
Ernco 200 LTD Pharmaceuticals: MajorHealth Technology Ernco 200 LTD manufactured pharmaceutical Foscan for cancer treatment, specializes in photodynamic therapy. The company was headquartered in Stirling, the United Kingdom. | Health Technology |
Warner Lambert (UK) Ltd.
Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Warner Lambert (UK) Ltd. is a manufacturer and wholesaler of pharmaceuticals and over the counter medicines. The private company is based in Eastleigh, UK. | Health Technology |
Alida Capital International Ltd.
 Alida Capital International Ltd. Investment ManagersFinance Alida Capital International Ltd. Provides capital and practical assistance for emerging biopharmaceutical companies. The company was founded by Hugh S. Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Finance |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The private company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Technology Services |
